Ipilimumab: Unleashing the Power of the Immune System Through CTLA-4 Blockade
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference70 articles.
1. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose interleukin 2;Rosenberg;JAMA,1994
2. Functions of anti-MAGE T-cells induced in melanoma patients under different vaccination modalities;Connerotte;Cancer Res,2008
3. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma;Dudley;J Clin Oncol,2005
4. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine;Morton;Ann Surg,1992
5. A phase III, randomized, double-blind, multicenter study comparing monotherapy with ipilimumab or gp100 peptide vaccine and the combination in patients with previously treated, unresectable stage III or IV melanoma;O’Day;J Clin Oncol (Meeting Abstracts),2010
Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. B cell epitope mapping: The journey to better vaccines and therapeutic antibodies;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-10
2. The association of hypophysitis with immune checkpoint inhibitors use: Gaining insight through the FDA pharmacovigilance database;Medicine;2024-03-29
3. Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy;Frontiers in Immunology;2023-10-23
4. Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know;American Journal of Neuroradiology;2023-08-17
5. The Role of Immune Checkpoint Inhibitors in Cancer Therapy;Clinics and Practice;2022-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3